相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A highly sensitive fluorescent probe that quantifies transthyretin in human plasma as an early diagnostic tool of Alzheimer's disease
Hye Rim Lim et al.
CHEMICAL COMMUNICATIONS (2019)
A novel bis-furan scaffold for transthyretin stabilization and amyloid inhibition
Carlos J. V. Simoes et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain
Apirat Chaikuad et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Enthalpic Forces Correlate with the Selectivity of Transthyretin-Stabilizing Ligands in Human Plasma
Irina Iakovleva et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Bifunctional coumarin derivatives that inhibit transthyretin amyloidogenesis and serve as fluorescent transthyretin folding sensors
Nojoon Myung et al.
CHEMICAL COMMUNICATIONS (2013)
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
Christine E. Bulawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Discovery of a Potent and Selective Hetero-Bivalent AChE Inhibitor via Bioisosteric Replacement
Orazio Nicolotti et al.
MOLECULAR INFORMATICS (2011)
Synthesis, Enzymatic Evaluation, and Docking Studies of Fluorogenic Caspase 8 Tetrapeptide Substrates
Przemyslaw Reszka et al.
CHEMMEDCHEM (2010)
Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses
Stephen Connelly et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2010)
A Substructure Combination Strategy To Create Potent and Selective Transthyretin Kinetic Stabilizers That Prevent Amyloidogenesis and Cytotoxicity
Sungwook Choi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Chemoselective small molecules that covalently modify one lysine in a non-enzyme protein in plasma
Sungwook Choi et al.
NATURE CHEMICAL BIOLOGY (2010)
Toward Optimization of the Second Aryl Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies
Steven M. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: The relationship between stability and amyloidosis
Amy R. Hurshman Babbes et al.
BIOCHEMISTRY (2008)
Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors
Steven M. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Toward Optimization of the Linker Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies
Steven M. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Design of mechanism-based inhibitors of transthyretin amyloidosis: Studies with biphenyl ethers and new structural templates
Sarika Gupta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: A focus on the transthyretin amyloidoses
SM Johnson et al.
ACCOUNTS OF CHEMICAL RESEARCH (2005)
Potent and selective structure-based dibenzofuran inhibitors of transthyretin amyloidogenesis: Kinetic stabilization of the native state
HM Petrassi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
The biological and chemical basis for tissue-selective amyloid disease
Y Sekijima et al.
CELL (2005)
Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation
SM Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid:: A prescription for central nervous system amyloidosis?
P Hammarström et al.
BIOCHEMISTRY (2003)
Prevention of transthyretin amyloid disease by changing protein misfolding energetics
P Hammarström et al.
SCIENCE (2003)
Benzoxazoles as transthyretin amyloid fibril inhibitors: Synthesis, evaluation, and mechanism of action
H Razavi et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Unfolding the role of protein misfolding in neurodegenerative diseases
C Soto
NATURE REVIEWS NEUROSCIENCE (2003)
Sequence-dependent denaturation energetics:: A major determinant in amyloid disease diversity
P Hammarström et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Therapeutic strategies for human amyloid diseases
JC Sacchettini et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors
VB Oza et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
分享论文
